Medicare Enrolled

Dr. James Orsini, MD

Hematology & Oncology · Belleville, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1 CLARA MAASS DR STE 200, Belleville, NJ 07109
9737518880
In practice since 2005 (20 years)
NPI: 1922084185 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Orsini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orsini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Orsini

Dr. James Orsini is a hematology & oncology specialist in Belleville, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Orsini performed 553 Medicare services across 251 unique beneficiaries.

Between the years covered by Open Payments, Dr. Orsini received a total of $47,666 from 48 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Orsini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 553 Medicare services $47,666 industry payments

Medicare Practice Summary

Medicare Utilization ↗
553
Medicare services
Bottom 27% in NJ for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
251
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
202 $8 $8
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
191 $8 $16
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
114 $103 $286
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
28 $146 $393
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
18 $54 $154
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.3% high complexity
0.0% medium
96.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$47,666
Total received (2018-2024)
Avg $6,809/year across 7 years
Top 6% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42,326 (88.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,358 (7.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,981 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$607
2023
$606
2022
$4,601
2021
$18,251
2020
$3,366
2019
$10,004
2018
$10,230

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$115
AstraZeneca Pharmaceuticals LP
$94
GlaxoSmithKline, LLC.
$56
E.R. Squibb & Sons, L.L.C.
$36
BeiGene USA, Inc.
$35
EMD Serono, Inc.
$34
Gilead Sciences, Inc.
$28
Acera Surgical, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
GENZYME CORPORATION
$22
ABBVIE INC.
$20
Adaptive Biotechnologies Corporation
$20
Karyopharm Therapeutics Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Celgene Corporation
$17
Novartis Pharmaceuticals Corporation
$15
Merck Sharp & Dohme LLC
$14
Janssen Biotech, Inc.
$14
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$24,877
Astellas Pharma US Inc
$16,791
Janssen Biotech, Inc.
$2,137
AstraZeneca Pharmaceuticals LP
$524
Incyte Corporation
$288
Novartis Pharmaceuticals Corporation
$276
E.R. Squibb & Sons, L.L.C.
$262
Bayer HealthCare Pharmaceuticals Inc.
$217
Amgen Inc.
$196
PFIZER INC.
$180
Genentech USA, Inc.
$147
Seattle Genetics, Inc.
$127
NeoTract Inc.
$122
Celgene Corporation
$113
Dendreon Pharmaceuticals LLC
$112
Gilead Sciences, Inc.
$109
Karyopharm Therapeutics Inc.
$102
BeiGene USA, Inc.
$102
ASD SPECIALTY HEALTHCARE, LLC
$94
GlaxoSmithKline, LLC.
$74
Pharmacyclics LLC, An AbbVie Company
$71
Merck Sharp & Dohme Corporation
$66
Takeda Pharmaceuticals U.S.A., Inc.
$52
Puma Biotechnology, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$45
Kite Pharma, Inc.
$42
Exelixis Inc.
$36
GENZYME CORPORATION
$35
Allergan Inc.
$34
EMD Serono, Inc.
$34
Lilly USA, LLC
$33
G1 Therapeutics, Inc.
$29
Daiichi Sankyo Inc.
$28
Acera Surgical, Inc.
$26
Sirtex Medical Inc
$24
Alexion Pharmaceuticals, Inc.
$24
Verastem, Inc.
$23
ABBVIE INC.
$20
Adaptive Biotechnologies Corporation
$20
Pharmacosmos Therapeutics Inc.
$18
Rigel Pharmaceuticals, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Janssen Scientific Affairs, LLC
$14
Merck Sharp & Dohme LLC
$14
Pharmacyclics LLC, an AbbVie Company
$14
Teva Pharmaceuticals USA, Inc.
$13
Heron Therapeutics, Inc.
$12
Ipsen Biopharmaceuticals, Inc
$11
Top 3 companies account for 91.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AVYCAZ · Abraxane · Aliqopa · Avastin · BRUKINSA · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · EPKINLY · ERLEADA · Erivedge · Erleada · GAZYVA · IMBRUVICA · IMFINZI · IMLYGIC · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PIQRAY · PROVENGE · REBLOZYL · RYDAPT · Restrata Wound Matrix · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · Stivarga · TAGRISSO · TECENTRIQ · Tavalisse · Trodelvy · Truxima · UroLift · VERZENIO · VIAGRA · Vitrakvi · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology & oncology in NJ.

Looking for a hematology & oncology specialist in Belleville?
Compare hematology & oncology specialists in the Belleville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
702
Per 100K population
82.2
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Orsini is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Orsini experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Orsini performed 202 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Orsini receive payments from pharmaceutical companies?
Yes. Dr. Orsini received a total of $47,666 from 48 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Orsini's costs compare to other hematology & oncology specialists in Belleville?
Dr. Orsini's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Orsini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →